Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Pharmaceuticals

Delayed NSE India S.E. 06:56:33 16/07/2024 BST 5-day change 1st Jan Change
1,025 INR +4.39% Intraday chart for Alembic Pharmaceuticals Limited +5.32% +35.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Alembic Pharmaceuticals Gets US FDA's Tentative Approval for Generic Hypertension Drug MT
Alembic Pharmaceuticals Limited Announces USFDA Tentative Approval for Selexipag for Injection, 1,800 Mc/Vial CI
Indian Equities Hit New Closing Highs Led by Auto Stocks MT
Alembic Pharmaceuticals Gets US FDA Final Nod for Bromfenac Ophthalmic Solution MT
Alembic Pharmaceuticals Announces Usfda Final Approval for Bromfenac Ophthalmic Solution, 0.07% CI
Alembic Pharmaceuticals Gets US FDA's Tentative Approval for Generic Leukemia Drug; Shares Up 3% MT
Alembic Pharmaceuticals Limited Receives USFDATentative Approval for Ivosidenib Tablets 250 Mg CI
Alembic Pharmaceuticals Gets US FDA's Tentative Approval for Generic Leukemia Drug; Shares Up 4% MT
Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Bosutinib Tablets, 100 Mg and 500 Mg CI
Alembic Pharmaceuticals Gets US FDA's Nod for Generic Inflammatory Skin Condition Drug MT
Alembic Pharmaceuticals Gets US FDA Nod for Dabigatran Etexilate Capsules MT
Alembic Pharmaceuticals Limited Receives Order from Office of the Commissioner of Customs CI
Alembic Pharmaceuticals Limited Receives Three Orders from Office of Director of Prohibition and Excise Department CI
Alembic Pharmaceuticals Gets US FDA's Final Approval for Generic Drug Angioedema MT
Alembic Pharmaceuticals Limited Announces Usfda Final Approval for Icatibant Injection, 30 Mg/3 Ml (10 Mg/Ml) Single-Dose Prefilled Syringe CI
Alembic Pharmaceuticals Limited Announces Superannuation of Chandrahas Shetty as President-Human Resources (India Branded Business) CI
Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets MT
Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Sacubitril and Valsartan Tablets, 24 Mg/26 Mg, 49 Mg/51 Mg, and 97 Mg/103 Mg CI
Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4 MT
India's Alembic Pharma posts higher Q4 profit on strong N.America sales RE
Alembic Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Alembic Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Alembic Pharmaceuticals Limited Recommends Dividend for the Financial Year 2023-24 CI
Alembic Pharmaceuticals Limited Receives Various US Food & Drug Administration (Tentative or Final) Product Approvals CI
Chart Alembic Pharmaceuticals Limited
More charts
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
981.8 INR
Average target price
981.2 INR
Spread / Average Target
-0.06%
Consensus
  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. News Alembic Pharmaceuticals Limited
  5. Alembic Pharmaceuticals Gets US FDA's Tentative Approval for Generic Hypertension Drug